altwood pharmacy limited Company Information
Company Number
04032546
Website
www.altwoodpharmacy.co.ukRegistered Address
47 wootton way, maidenhead, berkshire, SL6 4QZ
Industry
Dispensing chemist in specialised stores
Telephone
01628630283
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
hadi healthcare limited 100%
altwood pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ALTWOOD PHARMACY LIMITED at £175.6k based on a Turnover of £620.9k and 0.28x industry multiple (adjusted for size and gross margin).
altwood pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ALTWOOD PHARMACY LIMITED at £0 based on an EBITDA of £-1.1k and a 4.49x industry multiple (adjusted for size and gross margin).
altwood pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of ALTWOOD PHARMACY LIMITED at £295.8k based on Net Assets of £120.4k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Altwood Pharmacy Limited Overview
Altwood Pharmacy Limited is a live company located in berkshire, SL6 4QZ with a Companies House number of 04032546. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2000, it's largest shareholder is hadi healthcare limited with a 100% stake. Altwood Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £620.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Altwood Pharmacy Limited Health Check
Pomanda's financial health check has awarded Altwood Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
6 Weak
Size
annual sales of £620.9k, make it smaller than the average company (£12.3m)
- Altwood Pharmacy Limited
£12.3m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (6.4%)
- Altwood Pharmacy Limited
6.4% - Industry AVG
Production
with a gross margin of 30.9%, this company has a comparable cost of product (30.9%)
- Altwood Pharmacy Limited
30.9% - Industry AVG
Profitability
an operating margin of -0.6% make it less profitable than the average company (2.2%)
- Altwood Pharmacy Limited
2.2% - Industry AVG
Employees
with 8 employees, this is below the industry average (84)
8 - Altwood Pharmacy Limited
84 - Industry AVG
Pay Structure
on an average salary of £22.9k, the company has an equivalent pay structure (£22.9k)
- Altwood Pharmacy Limited
£22.9k - Industry AVG
Efficiency
resulting in sales per employee of £77.6k, this is less efficient (£128.1k)
- Altwood Pharmacy Limited
£128.1k - Industry AVG
Debtor Days
it gets paid by customers after 28 days, this is near the average (30 days)
- Altwood Pharmacy Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 62 days, this is close to average (67 days)
- Altwood Pharmacy Limited
67 days - Industry AVG
Stock Days
it holds stock equivalent to 45 days, this is more than average (30 days)
- Altwood Pharmacy Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 27 weeks, this is more cash available to meet short term requirements (15 weeks)
27 weeks - Altwood Pharmacy Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 41.8%, this is a lower level of debt than the average (61%)
41.8% - Altwood Pharmacy Limited
61% - Industry AVG
ALTWOOD PHARMACY LIMITED financials
Altwood Pharmacy Limited's latest turnover from September 2023 is estimated at £620.9 thousand and the company has net assets of £120.4 thousand. According to their latest financial statements, Altwood Pharmacy Limited has 8 employees and maintains cash reserves of £46.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||||
Other Income Or Grants | ||||||||||||||||
Cost Of Sales | ||||||||||||||||
Gross Profit | ||||||||||||||||
Admin Expenses | ||||||||||||||||
Operating Profit | ||||||||||||||||
Interest Payable | ||||||||||||||||
Interest Receivable | ||||||||||||||||
Pre-Tax Profit | ||||||||||||||||
Tax | ||||||||||||||||
Profit After Tax | ||||||||||||||||
Dividends Paid | ||||||||||||||||
Retained Profit | ||||||||||||||||
Employee Costs | ||||||||||||||||
Number Of Employees | 8 | 7 | 7 | 6 | 6 | 4 | 4 | 4 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 8,898 | 11,654 | 22,308 | 35,160 | 44,089 | 39,057 | 44,040 | 10,714 | 11,577 | 13,800 | 17,358 | 19,401 | 21,741 | 26,084 | 27,625 | 27,951 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35,314 | 44,143 | 52,972 | 61,801 | 70,630 | 79,459 | 88,288 | 97,117 | 105,946 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 8,898 | 11,654 | 22,308 | 35,160 | 44,089 | 39,057 | 44,040 | 46,028 | 55,720 | 66,772 | 79,159 | 90,031 | 101,200 | 114,372 | 124,742 | 133,897 |
Stock & work in progress | 54,096 | 39,035 | 0 | 0 | 0 | 0 | 0 | 46,184 | 50,278 | 56,411 | 62,781 | 95,773 | 91,287 | 131,493 | 134,633 | 119,758 |
Trade Debtors | 47,781 | 49,234 | 169,191 | 134,919 | 130,586 | 178,992 | 255,187 | 242,891 | 264,045 | 243,187 | 232,242 | 200,384 | 201,842 | 201,943 | 136,653 | 184,082 |
Group Debtors | 42,990 | 42,990 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 7,116 | 14,065 | 0 | 0 | 8,285 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 46,134 | 53,032 | 0 | 0 | 0 | 0 | 0 | 3,096 | 7,955 | 8,586 | 7,201 | 2,417 | 14,375 | 67,693 | 238,337 | 12,772 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 198,117 | 198,356 | 169,191 | 134,919 | 138,871 | 178,992 | 255,187 | 292,171 | 322,278 | 308,184 | 302,224 | 298,574 | 307,504 | 401,129 | 509,623 | 316,612 |
total assets | 207,015 | 210,010 | 191,499 | 170,079 | 182,960 | 218,049 | 299,227 | 338,199 | 377,998 | 374,956 | 381,383 | 388,605 | 408,704 | 515,501 | 634,365 | 450,509 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 73,225 | 62,564 | 123,447 | 148,500 | 168,078 | 215,832 | 201,879 | 233,114 | 259,049 | 230,039 | 211,438 | 194,421 | 229,284 | 322,192 | 427,669 | 230,109 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 13,399 | 25,654 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 86,624 | 88,218 | 123,447 | 148,500 | 168,078 | 215,832 | 201,879 | 233,114 | 259,049 | 230,039 | 211,438 | 194,421 | 229,284 | 322,192 | 427,669 | 230,109 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48,349 | 64,489 | 80,090 | 0 | 110,163 | 124,619 | 138,757 | 152,533 | 165,969 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 1,610 | 3,540 | 3,540 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 96,770 | 54,000 | 54,000 | 64,000 | 169,315 | 84,000 | 54,000 | 54,000 | 54,000 | 54,000 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 1,610 | 3,540 | 3,540 | 0 | 96,770 | 102,349 | 118,489 | 144,090 | 169,315 | 194,163 | 178,619 | 192,757 | 206,533 | 219,969 |
total liabilities | 86,624 | 88,218 | 125,057 | 152,040 | 171,618 | 215,832 | 298,649 | 335,463 | 377,538 | 374,129 | 380,753 | 388,584 | 407,903 | 514,949 | 634,202 | 450,078 |
net assets | 120,391 | 121,792 | 66,442 | 18,039 | 11,342 | 2,217 | 578 | 2,736 | 460 | 827 | 630 | 21 | 801 | 552 | 163 | 431 |
total shareholders funds | 120,391 | 121,792 | 66,442 | 18,039 | 11,342 | 2,217 | 578 | 2,736 | 460 | 827 | 630 | 21 | 801 | 552 | 163 | 431 |
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||||
Operating Profit | ||||||||||||||||
Depreciation | 2,756 | 863 | 2,223 | 3,558 | 3,538 | 4,658 | 4,343 | 4,657 | 16,472 | 17,529 | ||||||
Amortisation | 0 | 0 | 8,829 | 8,829 | 8,829 | 8,829 | 8,829 | 8,829 | 8,829 | 8,829 | 8,829 | |||||
Tax | ||||||||||||||||
Stock | 15,061 | 39,035 | 0 | 0 | 0 | -46,184 | -46,184 | -4,094 | -6,133 | -6,370 | -32,992 | 4,486 | -40,206 | -3,140 | 14,875 | 119,758 |
Debtors | -8,402 | -62,902 | 34,272 | -3,952 | -40,121 | -63,899 | 12,296 | -21,154 | 20,858 | 10,945 | 31,858 | -1,458 | -101 | 65,290 | -47,429 | 184,082 |
Creditors | 10,661 | -60,883 | -25,053 | -19,578 | -47,754 | -17,282 | -31,235 | -25,935 | 29,010 | 18,601 | 17,017 | -34,863 | -92,908 | -105,477 | 197,560 | 230,109 |
Accruals and Deferred Income | -12,255 | 24,044 | -1,930 | 0 | 3,540 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||||
Investing Activities | ||||||||||||||||
capital expenditure | ||||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||||
Financing Activities | ||||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | -48,349 | -48,349 | -16,140 | -15,601 | 80,090 | -110,163 | -14,456 | -14,138 | -13,776 | -13,436 | 165,969 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | -54,000 | 42,770 | 0 | -10,000 | -105,315 | 85,315 | 30,000 | 0 | 0 | 0 | 54,000 |
share issue | ||||||||||||||||
interest | ||||||||||||||||
cash flow from financing | ||||||||||||||||
cash and cash equivalents | ||||||||||||||||
cash | -6,898 | 53,032 | 0 | 0 | 0 | -3,096 | -3,096 | -4,859 | -631 | 1,385 | 4,784 | -11,958 | -53,318 | -170,644 | 225,565 | 12,772 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -6,898 | 53,032 | 0 | 0 | 0 | -3,096 | -3,096 | -4,859 | -631 | 1,385 | 4,784 | -11,958 | -53,318 | -170,644 | 225,565 | 12,772 |
altwood pharmacy limited Credit Report and Business Information
Altwood Pharmacy Limited Competitor Analysis
Perform a competitor analysis for altwood pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SL6 area or any other competitors across 12 key performance metrics.
altwood pharmacy limited Ownership
ALTWOOD PHARMACY LIMITED group structure
Altwood Pharmacy Limited has no subsidiary companies.
Ultimate parent company
ALTWOOD PHARMACY LIMITED
04032546
altwood pharmacy limited directors
Altwood Pharmacy Limited currently has 2 directors. The longest serving directors include Mr Sarmad Ali (Oct 2018) and Mr Ayad Ali (Nov 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Sarmad Ali | 65 years | Oct 2018 | - | Director | |
Mr Ayad Ali | 35 years | Nov 2018 | - | Director |
P&L
September 2023turnover
620.9k
+9%
operating profit
-3.9k
0%
gross margin
30.9%
-5.58%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
120.4k
-0.01%
total assets
207k
-0.01%
cash
46.1k
-0.13%
net assets
Total assets minus all liabilities
altwood pharmacy limited company details
company number
04032546
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
July 2000
age
24
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
47 wootton way, maidenhead, berkshire, SL6 4QZ
Bank
-
Legal Advisor
-
altwood pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to altwood pharmacy limited. Currently there are 1 open charges and 4 have been satisfied in the past.
altwood pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|